A phase II, randomised trial of Azixa in combination with temozolomide in patients with metastatic melanoma.

Trial Profile

A phase II, randomised trial of Azixa in combination with temozolomide in patients with metastatic melanoma.

Completed
Phase of Trial: Phase II

Latest Information Update: 23 Jun 2014

At a glance

  • Drugs Temozolomide; Verubulin
  • Indications Cancer metastases; Malignant melanoma
  • Focus Therapeutic Use
  • Most Recent Events

    • 23 Jun 2014 Planned number of patients changed to 450.
    • 23 Jun 2014 Planned number of patients changed from 450 to NULL.
    • 10 Nov 2010 Status changed from recruiting to completed, according to an EpiCept media release.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top